Abstract

BackgroundBacterial resistance to antibiotics is a growing health problem that is projected to cause more deaths than cancer by 2050. Consequently, novel antibiotics are urgently needed. Since more than half of the available antibiotics target the structurally conserved bacterial ribosomes, factors involved in protein synthesis are thus prime targets for the development of novel antibiotics. However, experimental identification of these potential antibiotic target proteins can be labor-intensive and challenging, as these proteins are likely to be poorly characterized and specific to few bacteria. Here, we use a bioinformatics approach to identify novel components of protein synthesis.ResultsIn order to identify these novel proteins, we established a Large-Scale Transcriptomic Analysis Pipeline in Crowd (LSTrAP-Crowd), where 285 individuals processed 26 terabytes of RNA-sequencing data of the 17 most notorious bacterial pathogens. In total, the crowd processed 26,269 RNA-seq experiments and used the data to construct gene co-expression networks, which were used to identify more than a hundred uncharacterized genes that were transcriptionally associated with protein synthesis. We provide the identity of these genes together with the processed gene expression data.ConclusionsWe identified genes related to protein synthesis in common bacterial pathogens and thus provide a resource of potential antibiotic development targets for experimental validation. The data can be used to explore additional vulnerabilities of bacteria, while our approach demonstrates how the processing of gene expression data can be easily crowd-sourced.

Highlights

  • Bacterial resistance to antibiotics is a growing health problem that is projected to cause more deaths than cancer by 2050

  • We identified genes related to protein synthesis in common bacterial pathogens and provide a resource of potential antibiotic development targets for experimental validation

  • While more bacterial pathogens were considered, we only analyzed bacteria that had at least 100 RNA sequencing (RNA-seq) samples based on Illumina technology found in the Sequence Read Archive [52]

Read more

Summary

Introduction

Bacterial resistance to antibiotics is a growing health problem that is projected to cause more deaths than cancer by 2050. More than half of the antibiotics currently in use target the bacterial ribosome, typically at the elongation step of protein synthesis [3], through direct or proximal binding of the peptidyl transferase center (PTC) which catalyzes peptide bond formation [4]. The antibiotics can be modified, pumped out, or degraded, lowering the intracellular concentration to non-toxic levels [3, 11] Another mechanism is ribosome protection, where the antibiotic is actively dislodged from the ribosome by ATP-binding cassette F (ABC-F) protein, as observed in many clinical isolates (e.g., Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Enterococcus faecalis and Listeria monocytogenes) [12,13,14]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call